FairScope Lab
EN 繁中 简中

ZTS

Valuation Healthcare · Drug Manufacturers - Specialty & Generic Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

22.88

PEG Ratio

0.30

Dividend Yield

-

Gross Margin

68.87%

Net Margin

25.26%

Revenue CAGR 3Y

5.38%

ROE

72.41%

ROA

15.59%

Buyback Yield

1.04%

Current Ratio

3.03

Magic Earn Yield

5.30%

Altman Z-Score

4.65

Fair Value River

Score

Valuation 60
Profitability 70
Growth 18
Health 97
Yield 17
← Back to Dashboard